Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pain and Therapy is Scopus-indexed (Q1, CiteScore 6.6), WoS SCIE, DOAJ. Published by Adis.
Checked against the index lists dated .
ISSN 2193-651XVerify ISSN ↗2193-8237Verify ISSN ↗
Publisher: Adis
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Anesthesiology and Pain Medicine | 16 / 147 | 89th | Q1 |
| Neurology (clinical) | 86 / 403 | 78th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 6.6.
Pain and Therapy is Q1 in Anesthesiology and Pain Medicine (rank 16 of 147) and Q1 in Neurology (clinical) (rank 86 of 403), by CiteScore 2025.
Pain and Therapy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.6, which places it in quartile Q1 at the 89th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.915, quartile Q1, with an H-index of 47.
The publisher lists an article processing charge of about US$7,400 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Pain and Therapy is published by Adis. Its print ISSN is 2193-651X and its online ISSN is 2193-8237.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Pain and Therapy has an h-index of 57 and a 2-year mean of 6.54 citations per paper (OpenAlex). Its Scopus CiteScore is 6.6, quartile Q1. On 2-year citations it ranks #4 of 145 Scopus journals in Anesthesiology and Pain Medicine.
Pain and Therapy published 111 papers in 2025; its busiest recent year was 2024 with 127. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (38.9%), United States (20.2%) and Italy (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (2.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.